United States · FDA National Drug Code directory

Ring Relief

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 17312-023_4606551b-3bef-8c1b-e063-6394a90a0160
Product NDC: 17312-023
Form: TABLET, ORALLY DISINTEGRATING
Composition / generic term: ARNICA MONTANA - CALCIUM SULFIDE - HYPERICUM PERFORATUM - LYCOPODIUM CLAVATUM SPORE - MERCURIUS SOLUBILIS - SALICYLIC ACID - SILICON DIOXIDE - ALLYLTHIOUREA -
Labeler: TRP Company
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start / end (source format): 20111201
Source listing expiry: 20261231

Source-listed ingredients

ARNICA MONTANA — 6 [hp_X]/1
CALCIUM SULFIDE — 13 [hp_X]/1
HYPERICUM PERFORATUM — 6 [hp_X]/1
LYCOPODIUM CLAVATUM SPORE — 12 [hp_X]/1
MERCURIUS SOLUBILIS — 13 [hp_X]/1
SALICYLIC ACID — 6 [hp_X]/1
SILICON DIOXIDE — 13 [hp_X]/1
ALLYLTHIOUREA — 6 [hp_X]/1

These values do not establish equivalence or a dose recommendation.

Packages

1 BOTTLE in 1 PACKAGE (17312-023-14) / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE · 17312-023-14

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →